Delivery optimization of erlotinib according to toxicity

May clinical practice go beyond research?

Antonio Passaro, Morena Fasano, Emilio Bria, Floriana Morgillo, Flavia Cantile, Daniele Alesini, Arianna Pellegrino, Enrico Cortesi, Fortunato Ciardiello

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)352-353
Number of pages2
JournalLung Cancer
Volume80
Issue number3
DOIs
Publication statusPublished - Jun 2013

Keywords

  • EGFR TKI
  • Erlotinib
  • NSCLC
  • Second-line

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this

Delivery optimization of erlotinib according to toxicity : May clinical practice go beyond research? / Passaro, Antonio; Fasano, Morena; Bria, Emilio; Morgillo, Floriana; Cantile, Flavia; Alesini, Daniele; Pellegrino, Arianna; Cortesi, Enrico; Ciardiello, Fortunato.

In: Lung Cancer, Vol. 80, No. 3, 06.2013, p. 352-353.

Research output: Contribution to journalArticle

Passaro, A, Fasano, M, Bria, E, Morgillo, F, Cantile, F, Alesini, D, Pellegrino, A, Cortesi, E & Ciardiello, F 2013, 'Delivery optimization of erlotinib according to toxicity: May clinical practice go beyond research?', Lung Cancer, vol. 80, no. 3, pp. 352-353. https://doi.org/10.1016/j.lungcan.2013.01.023
Passaro, Antonio ; Fasano, Morena ; Bria, Emilio ; Morgillo, Floriana ; Cantile, Flavia ; Alesini, Daniele ; Pellegrino, Arianna ; Cortesi, Enrico ; Ciardiello, Fortunato. / Delivery optimization of erlotinib according to toxicity : May clinical practice go beyond research?. In: Lung Cancer. 2013 ; Vol. 80, No. 3. pp. 352-353.
@article{9dff87ee604049c8b3cd305398c8191d,
title = "Delivery optimization of erlotinib according to toxicity: May clinical practice go beyond research?",
keywords = "EGFR TKI, Erlotinib, NSCLC, Second-line",
author = "Antonio Passaro and Morena Fasano and Emilio Bria and Floriana Morgillo and Flavia Cantile and Daniele Alesini and Arianna Pellegrino and Enrico Cortesi and Fortunato Ciardiello",
year = "2013",
month = "6",
doi = "10.1016/j.lungcan.2013.01.023",
language = "English",
volume = "80",
pages = "352--353",
journal = "Lung Cancer",
issn = "0169-5002",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Delivery optimization of erlotinib according to toxicity

T2 - May clinical practice go beyond research?

AU - Passaro, Antonio

AU - Fasano, Morena

AU - Bria, Emilio

AU - Morgillo, Floriana

AU - Cantile, Flavia

AU - Alesini, Daniele

AU - Pellegrino, Arianna

AU - Cortesi, Enrico

AU - Ciardiello, Fortunato

PY - 2013/6

Y1 - 2013/6

KW - EGFR TKI

KW - Erlotinib

KW - NSCLC

KW - Second-line

UR - http://www.scopus.com/inward/record.url?scp=84877131377&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877131377&partnerID=8YFLogxK

U2 - 10.1016/j.lungcan.2013.01.023

DO - 10.1016/j.lungcan.2013.01.023

M3 - Article

VL - 80

SP - 352

EP - 353

JO - Lung Cancer

JF - Lung Cancer

SN - 0169-5002

IS - 3

ER -